Antimicrobial resistance is on the rise, and its early detection and surveillance are critical to implement effective control measures. The aim of this study was to develop a rapid hierarchical clustering bioinformatic tool for application on antibiotic susceptibility testing (AST) results (resistant, intermediate, sensitive) of a series of Klebsiella pneumoniae clinical isolates from Algeria and from France for surveillance of antibiotic-resistance phenotypes. A total of 1011 K. pneumoniae strains were collected from August 2008 to December 2012: 221 clinical isolates from western Algeria and 790 clinical isolates from Marseille, France. AST against a panel of 16 antibiotics was done for all isolates. Results of AST were introduced into MultiExperiment Viewer (MeV) software to perform hierarchical clustering, with resistant, intermediate and sensitive being translated to 1, 0 and "1 values, respectively. Hierarchical clustering results were compared to standard resistance phenotypes to evaluate the accuracy of the method. Based on the AST results, the 221 K. pneumoniae strains from Algeria could be separated into six phenotype groups as regards their resistance to b-lactam compounds: extended spectrum blactamase (ESBL) (68.3 %), ESBL associated with cephalosporinase (13.1 %), cephalosporinase (0.9 %), penicillinase (3.6 %) and wild-type (14.0 %). Hierarchical clustering by the MeV software applied to the AST results for all 1011 isolates generated clusters that were significantly representative of phenotypic classification and geographical origin, in less than 1 min. Moreover, adding to the dataset the AST results of a K. pneumoniae NDM-1 positive strain, the only strain resistant to imipenem in the series, immediately generated a new branch in the dendrogram. We have developed a rapid and simple hierarchical clustering tool for application on AST results that was able to survey qualitatively and quantitatively the prevalence of known and unknown phenotypes. This tool could be easily implemented in routine clinical microbiology laboratories.
INTRODUCTION
Concern is growing about increasing antimicrobial resistance worldwide (Giske et al., 2010) . International spread of antimicrobial-resistant micro-organisms suggests that such resistance should be regarded as a global problem that requires a common strategy and justifies specific surveillance involving major financial and intellectual resources throughout the world (Monnet, 2000; Bush et al., 2011) . Such surveillance is conducted in many countries and is now recognized as a priority for scientific societies, public health officers and legislators in order to detect outbreaks in their early stages (PAHO, 2000; Giske et al., 2010) . Outbreaks generally begin in small areas and subsequently spread widely. In order to detect an outbreak in its early stages, observation and counting of data remain critical (Hashimoto et al., 2000) . Nevertheless, poor data management, especially in low-income countries, prevents routine monitoring and reliable data collection to evaluate the prevalence of antimicrobial resistance and to survey multidrug-resistant bacteria (Bush et al., 2011; WHO, 2011) . Many guidelines worldwide have investigated the detection of outbreaks through surveillance systems such as the European Surveillance of Antibiotic Resistance (ESAR), the European Antimicrobial Resistance Surveillance System (EARSS) and the WHO Collaborative Center for Surveillance of Antimicrobial Resistance (Giske et al., 2010; Cornaglia et al., 2004) . However, such surveillance is usually not done in a real-time manner and depends on microbiological expertise that is not useful to immediately alert clinicians if a multidrug-resistant strain is detected to avoid the spread of strains and occurrence of an outbreak (Bush et al., 2011; WHO, 2011) .
This may have significant and dramatic consequences such as the establishment of endemic strains, e.g. carbapenem (KPC)-producing Klebsiella pneumoniae recently reported throughout Greece and Israel (Giakkoupi et al., 2011; Adler & Carmeli, 2011) . The most important questions regarding increasing resistance concern the potential rise in morbidity, mortality and costs (de Kraker et al., 2011) . For instance, in Europe in 2007, the number of infections by multidrug-resistant bacteria was 400 000, and there were 25 000 attributable deaths (Bush et al., 2011) .
The real-time detection of a new, rare or emerging resistant phenotype may be achieved only if the data from antibiotic susceptibility testing are evaluated automatically in a rapid and simple way. Such methods should be easy to perform and able to be adapted in any laboratory without molecular techniques. We might be able to detect the emergence and spread of new antibiotic-resistance encoding genes as recently exemplified by the New Delhi metallo-b-lactamase (NDM-1)-encoding gene spreading worldwide in Gram-negative bacteria (Rolain et al., 2010; Walsh et al., 2011) . K. pneumoniae is one of the most recent examples of such bacteria often isolated from patients with pneumonia, bloodstream and urinary tract infections, and has emerged worldwide as a multidrugresistant bacterium (Brisse & Verhoef, 2001; Gupta et al., 2003) . These bacteria may acquire multiple resistances and pose specific problems including outbreaks and rapid spread and circulation between patients (Nordmann et al., 2009; Podschun & Ullmann, 1998) .
The aim of this study was to evaluate and monitor the prevalence of antimicrobial resistance in K. pneumoniae strains isolated in western Algeria and in Marseille, France, and to develop a rapid bioinformatic tool to apply to the antibiotic susceptibility testing results (resistant, intermediate, sensitive: R, I, S) for surveillance of antibioticresistance phenotypes, using an original approach of hierarchical clustering with MultiExperiment Viewer (MeV) software. MeV software has been previously developed to analyse complex data obtained with DNA microarrays, and to process data from array comparative genomic hybridization (aCGH) and protein-protein interaction (PPI) experiments (Howe et al., 2010) .
METHODS
Ethics statement. All bacterial strains studied were taken from a collection of bacteria stored in the microbiology laboratory of the Université Abou Bekr Belkaid -Tlemcen, Algeria, and from the Marseille hospital collection. Only bacterial isolates from this collection were used, retrospectively, for epidemiological purposes and the study did not involve human participants; thus ethics approval was not necessary.
Bacterial isolates. A total of 221 non-redundant clinical strains of K. pneumoniae isolated from August 2008 to February 2011 in three different hospitals from western Algeria (Tlemcen, Sidi Bel Abbes and Oran Hospitals) were used in this study. The isolates were recovered from hospital clinical samples (one isolate per patient); details are given in Table 1 . One carbapenem-resistant K. pneumoniae strain (NDM-1), previously described in our laboratory (Diene et al., 2011) , along with 790 K. pneumoniae clinical isolates collected between January and December 2012 in Marseille hospital were used retrospectively as comparative strains in MeV software analysis.
K. pneumoniae NCTC 13443 and KPC-3 U2A 2246 were used as positive control strains for PCR assays of the bla TEM , bla SHV , bla CTX-M , bla KPC and bla NDM genes.
K. pneumoniae identification. Strains were cultured on MacConkey agar plates at 37 uC for 24 h; they were first identified using the API20E system (bioMérieux) and confirmed using a MALDI-TOF-MS spectrometer (337 nm) (Autoflex, Bruker Daltonics) with the FLEX control software (Bruker Daltonics) as previously described (Seng et al., 2009) . Antibiotic susceptibility. Antibiograms were determined by disc diffusion methods on Mueller-Hinton medium according to the Hierarchical clustering for surveillance of resistance guidelines of the Clinical and Laboratory Standards Institute (CLSI) (http://www.clsi.org/). Escherichia coli ATCC 25922 was used as a control strain. Antibiotic test discs were purchased from Bio-Rad and were as follows: ampicillin (10 mg), amoxicillin (25 mg), amoxicillin/ clavulanic acid (20/10 mg), ticarcillin (75 mg), cefalotin (30 mg), cefoxitin (30 mg), ceftazidime (30 mg), cefotaxime (30 mg), ceftriaxone (30 mg), imipenem (10 mg), gentamicin (10 mg), amikacin (30 mg), tobramycin (10 mg), ciprofloxacin (5 mg), trimethoprim/ sulfamethoxazole (1.25/23.75 mg), colistin (50 mg). In addition, imipenem and colistin MICs were determined using Etest strips, according to the instructions of the manufacturer (bioMérieux). The presence of extended-spectrum b-lactamase (ESBL) activity was detected by the double-disc synergy test as previously described (Jarlier et al., 1988) . Cephalosporinase inhibition, evaluated by the disc diffusion method on Mueller-Hinton agar containing cloxacillin at 250 mg l 21 , was performed for strains with decreased diameter to third-generation cephalosporins without synergy picture in order to search for high-level cephalosporinase production (Giraud-Morin & Fosse, 2008).
Antibiotic-resistance phenotypic classification of K. pneumoniae strains based on b-lactam compounds. We considered a wild-type (WT) phenotype as a strain that showed resistance to aminopenicillins, carboxypenicillins and ureidopenicillins. The penicillinase high-level phenotype (Pase) was indicated by a high penicillinase activity responsible for resistance to aminopenicillins and their inhibitors, to carboxypenicillins, to ureidopenicillins and to first-generation cephalosporins (1GC). The resistance may extend to the 2GC. The penicillinase-inhibitor-resistant TEM (Pase IRT) phenotype included resistance to aminopenicillins, carboxypenicillins and ureidopenicillins. However, it was distinguished by resistance to aminopenicillins and carboxypenicillins associated with the b-lactam inhibitors. 1GC generally retain their activity. The ESBL phenotype includes resistance to penicillins and cephalosporins except cephamycins. However, resistance to 3GC and 4GC was more or less pronounced depending on the enzymes and the strains (MIC of ,1 to 128 mg ml 21 ). Most of the ESBL were more sensitive to b-lactam inhibitors. The cephalosporinase (Case) phenotype corresponded to a marked resistance to penicillins, 1GC, 2GC, and to at least one 3GC. Cephamycins are not active. 3GC resistance may be fully or partially restored in the presence of cloxacillin. .4) 20(20.4) 98(100) 23(23.5) 14(14.3) 71(72.5) 42(42.8) 55(56.1) 98(100) Total R 221 (100) 221(100) 116(52.48) 221(100) 188(85.07) 5(2.26) 166(75.11) 180(81.48) 180(81.48) 0(0) 177 (80.1) 173(78.3) 47(21.3) 139(62.9) 145(65.6) .1) 40(18.1) 221(100) 41(18.5) 33(14.9) 166(75.1) 73(33) 68(30.8) 221(100) PCR amplification and sequencing. A single colony of each isolate from Algeria was resuspended in 400 ml water and boiled for 15 min. After centrifugation, the resulting supernatant was used as a bacterial template DNA in PCR assays in order to detect b-lactamase-encoding genes. Primer pairs were as previously described: bla TEM (Kruger et al., 2004) , bla SHV (Yagi et al., 2000) , bla CTX-M (Edelstein et al., 2003) , bla KPC (Bradford et al., 2004) and bla NDM (Diene et al., 2011) . Thermocycler conditions were as follows: an initial denaturation step at 95 uC for 15 min, followed by 35 cycles of denaturation at 94 uC for 1 min, annealing at 55 uC for 50 s and extension at 72 uC for AM 221 strains of K. pneumoniae
Hierarchical tree of b-lactam susceptibility testing results of the 221 K. pneumoniae strains from Algeria and K. pneumoniae NDM-1 (imipenem resistant). (a) The tree was divided into six clusters: C1 containing two strains with the penicillinase IRT phenotype, C2 containing 31 strains with a wild-type phenotype, C3 containing six strains with the high-level penicillinase phenotype, C4 containing two strains with the cephalosporinase phenotype, C5 and C6 containing 113 and 67 strains respectively, both with the ESBL phenotype alone or in association with cephalosporinase. (b) The addition of the antibiotic susceptibility testing results of K. pneumoniae NDM-1 (imipenem resistant) to the other results led to the immediate appearance of a new cluster representing this new phenotype. See Table 2 for antibiotic abbreviations. Hierarchical clustering for surveillance of resistance 1 min 30 s. Tubes were incubated at 72 uC for 7 min to ensure complete synthesis of the entire sequence. Positive PCR products were sequenced using BigDye terminator chemistry on an automated ABI 3730 sequencer (Applied Biosystems) based on Sanger's sequencing method (Sanger et al., 1977) . Data collection and analysis were performed using CodonCode Aligner 3.7.1.1 sequencing analysis software.
Hierarchical clustering. Antibiogram results (R, I, S) of the 16 antibiotics tested were recorded in an Excel file and automatically coded as follows: '1' corresponds to resistant, '0' to intermediate and '21' to susceptible. This resulted in a 221616 matrix. Rows represented all collected strains (221 strains) and columns represented the 16 antibiotics tested. We started by analysing b-lactam antibiotics (ten antibiotics) to correlate the hierarchical clustering with the antibiotic-resistance phenotypes based on b-lactam antibiotics then we added the other classes of antibiotics to highlight the associated resistance. Hierarchical clustering of data, based on the three values attributed, was carried out using MeV v4.6.2 software (http://www.tm4.org/). Our matrix was presented graphically by colouring each antibiotic susceptibility testing result on the basis of measured colour range: lower limit '21' was coloured blue, upper limit '1' was coloured red and midpoint value '0' was coloured black.
A hierarchical clustering algorithm usually requires two main steps that are repeated in order to find the strains that are most similar: assigning the antibiogram result values from the same strain to its own cluster, and merging the two clusters that are closest to each other until only one big cluster results. In this study, hierarchical clustering was applied on the results of antibiotic susceptibility testing of all the strains; Pearson correlation was used as distance metric and the complete linkage method was used (details of the algorithm are given as supplementary data, available with the online version of this paper). To reduce the complexity of the tree, the algorithm produces a node height which displays the number of terminal nodes in the tree by imposing a distance threshold according to the classification. Strains on nodes which had distances below this threshold were considered as one cluster and the lower-level detail of the tree was ignored.
Statistical analyses. Statistical analyses of the antibiotic-resistance phenotypes of strains distributed in each cluster were performed by chi-squared calculation using Epi Info version 3.4.1 software (CDC, Atlanta, GA, USA) by comparing each cluster to the whole collection. Differences were considered statistically significant at P,0.05.
RESULTS

K. pneumoniae strains from Algeria
Using MALDI-TOF-MS, all K. pneumoniae strains (100 %) identified by API20E were confirmed with score values .1.9. Among the 221 isolates, 99 (44.8 %) were recovered from tracheal aspirations, 53 (24.0 %) from pus, 30 (13.6 %) from urine and 39 (17.6 %) from other different clinical samples. Details are given in Table 1 .
Antibiotic susceptibility testing of K. pneumoniae strains from Algeria
The K. pneumoniae strains showed a high degree of multiresistance ( Table 3 for details of phenotypes. dSee Table 2 for antibiotic abbreviations.
Most ESBL strains showed co-resistance to aminoglycosides (71.5 %), ciprofloxacin (75.0 %) and trimethoprim/sulfamethoxazole (75.5 %) ( 
Hierarchical clustering
Hierarchical clustering of the K. pneumoniae antibiotic susceptibility testing results was carried out using MeV software; strains were counted and automatically classified into clusters according to their antibiotic-resistance phenotypes in less than 1 min. Strains from Algeria were confidently separated into six clusters based on their susceptibility profile to b-lactam compounds (Fig. 1a) .
Each cluster was in perfect correlation with that of the blactamase phenotypic classification, with highly significant P-values (Table 5) . Interestingly, adding the antibiotic susceptibility testing results of a K. pneumoniae strain resistant to imipenem (containing bla NDM-1 ) led to the immediate and automatic appearance of a new cluster representing this new phenotype (Fig. 1b ). In the same way, by adding susceptibility testing results for the other classes of antibiotics to those of b-lactams, strains were significantly separated into six clusters associated with specific antibiotic-resistance phenotypes based on blactams, aminoglycosides, fluoroquinolones and sulfonamides (Fig. 2 , Table 5 ). In order to confirm that the hierarchical clustering was a simple and accurate method to trace isolates according to their phenotypes and geographical locations, we added to our dataset the 790 antibiotic susceptibility profiles obtained retrospectively from K. pneumoniae clinical isolates from Marseille, France. It should be noted that the delay from extraction of antibiotic susceptibility testing of these strains and coding R, I, S to 1, 0, 21 took only 40 min and reconstruction of the new hierarchical clustering containing these 1012 profiles took only 1 min. Analysis of this Hierarchical tree of antibiotic susceptibility testing results with all antibiotics of the 221 K. pneumoniae strains from Algeria and K. pneumoniae NDM-1 (imipenem resistant). The tree was divided into six clusters. C1 contained strains sensitive to non-b-lactam antibiotics and C2 contained four variable combinations of associated resistance. These two clusters (C1 and C2) were significantly associated with non-ESBL-producing strains. C3, C4 and C5 were significantly associated with ESBLproducing strains and each of them contained significant combination of associated resistance, C6 containing the NDM-1 strain resistant to all antibiotics except colistin. See Table 2 for antibiotic abbreviations.
new clustering reveals that it contains seven clusters: C1 to C3 being WT phenotype, C4 being Pase phenotype, C5 and C6 being ESBL phenotype with or without Case, and C7 being the K. pneumoniae strain resistant to imipenem (containing bla NDM-1 ) (Fig. 3) . Interestingly, the NDM-1 profile was alone in the clustering, as in Fig. 1(b) . Each cluster was in perfect correlation with that of the blactamase phenotypic classification (Table 6) . A more precise analysis of the two clusters containing ESBL profiles showed that 150 out of 230 ESBL-producing isolates from Marseille clustered in C5 along with only 4 out of 180 isolates from Algeria, whereas the remaining 80 ESBL-producing isolates from Marseille clustered in C6 with 176 ESBL strains from Algeria (P,10 26 ) (Fig. 3) . Details of the distribution of all phenotypes of the Algeria and Marseille strains are given in Table 7 .
DISCUSSION
Since the beginning of the 21st century, K. pneumoniae has become a major cause of severe nosocomial infections that are difficult to treat. Outbreaks are caused by strains resistant to a wide variety of antibiotics (de Melo et al., 2011) . The analysis of results obtained in this study Fig. 3 . Hierarchical tree of antibiotic susceptibility testing results with all antibiotics for the 1011 K. pneumoniae strains from Algeria and Marseille, France, and K. pneumoniae NDM-1 (imipenem resistant). The tree was divided into seven clusters: C1, C2 and C3 containing wildtype strains with (C1 and C3) or without (cluster C2) associated resistance to other antibiotics; C4 containing Pase phenotype strains; C5 and C6 containing ESBL-producing strains, with cluster C5 being significantly associated with strains from Marseille and cluster C6 being significantly associated with strains from Algeria; and C7 containing the NDM-1 strain resistant to all antibiotics except colistin. See Table 2 (Ducki & Blech, 2004) , Northern Europe with 16.7 % (Khan et al., 2010) , South Korea with 32 % (Kim et al., 2008) , South America with 51.9 % (Turner, 2005) and Tunisia with 75 % (Boutiba-Ben Boubaker et al., 2002) . All our ESBL-producing isolates were susceptible to imipenem, which is similar to other Algerian studies (Messai et al., 2008; Sekhri-Arafa et al., 2010) . Nevertheless, universal susceptibility to these last-line antimicrobials in Enterobacteriaceae is no longer guaranteed because of the emergence of carbapenemaseencoding genes such as NDM, IMP, KPC, GES and OXA-48 that should be surveyed cautiously (Nordmann & Carrer, 2010; Cuzon et al., 2011) .
In this work, the cluster analysis technique was used as an exploratory method that provided a clear and succinct summary tree to look for diversity of resistance phenotype with the approach taken by Eisen et al. (1998) . Our hierarchical clustering proved an easy and rapid tool able to group susceptibility testing results of a large series of strains in less than 1 min into clusters and to count them, according to the different specific resistance phenotype groups. Interestingly, clusters obtained using antibiotic susceptibility profiles from strains from Algeria and France allowed us to confidently and significantly separate the ESBL producers isolated in Marseille from those isolated in Algeria. This means that ESBL strains from Marseille were different from those from Algeria, likely suggesting that there are different endemic strains in these two countries. Since antibiotic susceptibility testing methods are likely similar worldwide it should be possible to share data from different countries and to use this method to trace clonal expansion of individual isolates from different countries, cities or hospitals. Moreover, we now use this method for real-time surveillance of the evolution and expansion of these clusters in Marseille hospitals in order to be able to detect specifically an outbreak and/or appearance of a new cluster. The numbers of strains in each cluster are compared every month to our local database using our epidemiological surveillance software EPIMIC, recently developed in the Clinical Microbiology Laboratory of University Hospitals in Marseille (Parola et al., 2011; Kempf et al., 2013) . Such simple software may be useful to improve rapid detection of new resistance mechanisms, to compare resistance levels, and to share and to improve the control of antimicrobial resistance in real time. It can be combined with an in-house locally used software, such as EPIMIC, which is used to automatically count and detect an outbreak by comparing both the numbers of samples received and pathogens diagnosed to historical data as soon as they are entered; any significant increase beyond the critical threshold, defined by means of historical data plus two standard deviations, generates a signal alert (Parola et al., 2011) . Several systems, including VITEK 2 and SIRWEB, incorporate expert systems to control the results of susceptibility testing by applying a series of predefined rules which detect frequent or infrequent phenotypes. However, such a system is unable to classify and count different antibiotic-resistance phenotypes and cannot survey the prevalence of unknown phenotypes that may spread locally in a hospital (Joyanes et al., 2001) . In addition, laboratories in low-income countries generally lack these systems because of the cost, so their data cannot be shared and compared with other laboratories and countries to provide an early warning of new or unusual outbreaks of drug-resistant bacteria (Bush et al., 2011; WHO, 2011) .
CONCLUSION
Antimicrobial resistance among K. pneumoniae strains is a major global public health problem. We believe that our hierarchical clustering approach will help microbiologists to survey the evolution of resistance phenotypes in real time to avoid rapid spread of endemic bacteria (Giakkoupi et al., 2011; Adler & Carmeli, 2011) . The high prevalence of resistance of K. pneumoniae to thirdgeneration cephalosporins in Algeria is worrying because this will likely increase the use of carbapenem compounds, Table 3 for details of phenotypes.
Hierarchical clustering for surveillance of resistance Table 3 for details of phenotypes. DSee Table 2 for antibiotic abbreviations. dStrains isolated from Marseille Hospital. §Strains isolated in Algerian hospitals.
